Matthew Korenberg Insider Profile

4 Followers
Matthew Korenberg, President & COO at Ligand Pharma, holds 50.78K shares in Ligand Pharma (Ticker: LGND), holds ― shares in Qualigen Therapeutics (Ticker: QLGN), holds 24.55K shares in Lifecore Biomedical (Ticker: LFCR).
tipranks
Matthew Korenberg

Matthew Korenberg
Ligand Pharma (LGND)
President & COO

Ranked #36,256 out of 99,218 Corporate Insiders

Profitable Transactions

29%
2 out of 7 Profitable Transactions

Average Return

+2.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
97.48%
2.52%
0.00%
A breakdown of Matthew Korenberg's holdings

Insider Roles

Ligand Pharma
(LGND)
President & COO
Lifecore Biomedical
(LFCR)
Director
Qualigen Therapeutics
(QLGN)
Director
Roles that Matthew Korenberg holds in companies

Most Profitable Insider Trade

Stock:
Ligand Pharma
(LGND)
Rating:Informative Sell
Date:Aug 29, 2018 - Aug 29, 2019
Return:+64.30%
The most profitable trade made by Matthew Korenberg

Matthew Korenberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Sep 24, 2024
President & COO
Uninformative Buy
764.28K
$5.59M
Qualigen Therapeutics
Director
Lifecore Biomedical
Aug 21, 2024
Director
Uninformative Buy
$144.25K
List of latest transactions for each holding click on a transaction to see Matthew Korenberg's performance on stock

Matthew Korenberg insider profile FAQ

What is the percentage of profitable transactions made by Matthew Korenberg?
The percentage of profitable transactions made by Matthew Korenberg is 29%.
    What is the average return per transaction made by Matthew Korenberg?
    The average return per transaction made by Matthew Korenberg is 2.40%.
      What stocks does Matthew Korenberg hold?
      Matthew Korenberg holds: LGND, QLGN, LFCR stocks.
        What was Matthew Korenberg’s latest transaction?
        Matthew Korenberg latest transaction was an Uninformative Buy of $764.28K.
          What was Matthew Korenberg's most profitable transaction?
          Matthew Korenberg’s most profitable transaction was an Informative Sell of LGND stock on August 29, 2018. The return on the trade was 64.30%.
            What is Matthew Korenberg's role in Ligand Pharma?
            Matthew Korenberg's role in Ligand Pharma is President & COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.